- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- monomer
- Ligands
- 14 x NO3: NITRATE ION(Non-functional Binders)
- 1 x JWY: N-{4-chloro-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-N'-phenylurea(Non-covalent)
JWY.15: 22 residues within 4Å:- Chain A: V.38, A.56, V.57, K.58, E.75, L.79, L.82, V.89, V.103, T.105, E.106, Y.107, C.108, G.111, L.160, H.167, L.176, I.185, C.186, D.187, F.188, A.191
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:V.38, A:A.56, A:K.58, A:L.82, A:V.103, A:T.105, A:L.160, A:I.185, A:F.188, A:A.191
- Hydrogen bonds: A:K.58, A:E.75, A:C.108, A:C.108, A:D.187
- Water bridges: A:E.75
- pi-Cation interactions: A:K.58
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, B.D. et al., Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer Cell (2019)
- Release Date
- 2019-07-31
- Peptides
- Mast/stem cell growth factor receptor Kit: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- monomer
- Ligands
- 14 x NO3: NITRATE ION(Non-functional Binders)
- 1 x JWY: N-{4-chloro-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl}-N'-phenylurea(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, B.D. et al., Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer Cell (2019)
- Release Date
- 2019-07-31
- Peptides
- Mast/stem cell growth factor receptor Kit: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A